Crude model | Model 1* | Model 2† | |||||||||||||
Q1 | Q2 | Q3 | Q4 | P trend | Q1 | Q2 | Q3 | Q4 | P trend | Q1 | Q2 | Q3 | Q4 | P trend | |
General Obesity | 1 | 1.06 0.97±1.16 | 1.13 1.03±1.24 | 1.10 1.01±1.20 | 0.01 | 1 | 1.04 0.95±1.14 | 1.09 0.99±1.19 | 1.08 0.99±1.19 | 0.04 | 1 | 1.03 0.93±1.69 | 1.09 0.99±1.13 | 1.04 0.95±1.15 | 0.19 |
MetS | 1 | 1.07 0.98±1.16 | 1.14 1.05±1.24 | 1.09 1.01±1.19 | 0.008 | 1 | 1.04 0.95±1.12 | 1.09 1.01±1.19 | 1.06 0.98±1.16 | 0.06 | 1 | 1.04 0.95±1.13 | 1.08 0.98±1.18 | 1.03 0.94±1.13 | 0.35 |
Abdominal obesity | 1 | 1.04 0.95±1.14 | 1.09 1.00±1.19 | 1.07 0.98±1.17 | 0.06 | 1 | 1.02 0.93±1.12 | 1.05 0.96±1.15 | 1.04 0.95±1.14 | 0.31 | 1 | 1.03 0.93±1.13 | 1.03 0.93±1.14 | 0.98 0.93±1.69 | 0.80 |
High FBG | 1 | 0.24 0.14±0.34 | 0.17 0.08±0.27 | 0.12 0.03±0.21 | <0.001 | 1 | 0.14 0.05±0.23 | 0.19 0.10±0.29 | 0.09 0.09±0.18 | <0.001 | 1 | 1.01 0.99±1.11 | 0.17 0.08±0.28 | 0.11 0.02±0.21 | 0.004 |
High TG | 1 | 0.14 0.04±0.24 | 0.11 0.02±0.21 | 0.10 0.00±0.19 | 0.01 | 1 | 0.09 0.00±0.19 | 0.10 0.01±0.20 | 0.07 0.00±1.17 | <0.001 | 1 | 0.19 0.09±0.29 | 0.19 0.09±0.30 | 0.14 0.05±0.25 | 0.001 |
High BP | 1 | 1.07 0.99±1.16 | 1.07 0.99±1.16 | 1.04 0.97±1.13 | 0.22 | 1 | 1.06 0.98±1.14 | 1.04 0.96±1.12 | 1.02 0.94±1.11 | 0.58 | 1 | 1.05 0.96±1.14 | 1.03 0.94±1.20 | 0.99 0.91±1.08 | 0.83 |
Low HDL-C | 1 | 1.02 0.92±1.14 | 1.10 0.99±1.22 | 1.12 1.00±1.24 | 0.01 | 1 | 0.99 0.89±1.10 | 1.05 0.94±1.17 | 1.04 0.94±1.16 | 0.28 | 1 | 0.95 0.84±1.07 | 1.03 0.91±1.15 | 0.99 0.88±1.12 | 0.74 |
Crude model: without adjustment.
*Model 1: adjusted for age, sex.
†Model 2 for general obesity, MetS, abdominal obesity, high FBG, high TG, high BP, low HDL-C: adjusted as model 1 plus education levels (>14 and ≤14 years), smoking (never smoked, ex-smoker and current smoker), physical activity, baseline body mass index and energy intake.
BP, blood pressure; FBG, fasting blood glucose; HDL-C, high density lipoprotein cholesterol; MetS, metabolic syndrome; TG, triglyceride.